Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W McCaughan

Showing results (61-70 of 206) with videos related to

Pageof 21
Sort By:
Transplantation Proceedings|October 1, 1989
The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantationR Bell, A G Sheil, J A McDonald, et al.
Transplantation|July 1, 1993
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejectionY Matsumoto, G W McCaughan, D M Painter, et al.
Immunology Today|September 18, 1997
Microchimerism and transplant toleranceG A Bishop, G W McCaughan, J Sun, et al.
Transplantation Proceedings|October 1, 1992
Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1 beta, IL-6, IFN-gamma, and basic fibroblast growth factorG A Bishop, Y Matsumoto, G W McCaughan, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidasesC A Abbott, D Yu, G W McCaughan, et al.
Transplantation Proceedings|June 1, 1995
Quantitation of cytokine mRNA expression in biopsies from human liver allografts by a novel reverse transcriptase/polymerase chain reaction methodK L Rokahr, G W McCaughan, J Napoli, et al.
Immunogenetics|January 1, 1994
Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) geneC A Abbott, E Baker, G R Sutherland, et al.
Australian and New Zealand Journal of Medicine|February 1, 1982
The importance of hepatitis B infection in the aetiology of chronic hepatitis: a Sydney hospital experienceG W McCaughan, C Parsons, R G Batey, et al.
Transplantation|December 10, 1997
High-dose/activation-associated tolerance: a mechanism for allograft toleranceG A Bishop, J Sun, A G Sheil, et al.
Transplant Immunology|January 1, 1993
Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplificationG A Bishop, K L Rokahr, J Napoli, et al.
Pageof 21

Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Transplantation Proceedings|October 1, 1989
The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantationR Bell, A G Sheil, J A McDonald, et al.
Transplantation|July 1, 1993
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejectionY Matsumoto, G W McCaughan, D M Painter, et al.
Immunology Today|September 18, 1997
Microchimerism and transplant toleranceG A Bishop, G W McCaughan, J Sun, et al.
Transplantation Proceedings|October 1, 1992
Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1 beta, IL-6, IFN-gamma, and basic fibroblast growth factorG A Bishop, Y Matsumoto, G W McCaughan, et al.
Advances in Experimental Medicine and Biology|June 13, 2000
Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidasesC A Abbott, D Yu, G W McCaughan, et al.
Transplantation Proceedings|June 1, 1995
Quantitation of cytokine mRNA expression in biopsies from human liver allografts by a novel reverse transcriptase/polymerase chain reaction methodK L Rokahr, G W McCaughan, J Napoli, et al.
Immunogenetics|January 1, 1994
Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) geneC A Abbott, E Baker, G R Sutherland, et al.
Australian and New Zealand Journal of Medicine|February 1, 1982
The importance of hepatitis B infection in the aetiology of chronic hepatitis: a Sydney hospital experienceG W McCaughan, C Parsons, R G Batey, et al.
Transplantation|December 10, 1997
High-dose/activation-associated tolerance: a mechanism for allograft toleranceG A Bishop, J Sun, A G Sheil, et al.
Transplant Immunology|January 1, 1993
Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplificationG A Bishop, K L Rokahr, J Napoli, et al.
Pageof 21